Endometriosis and Mental Health: The Brain-Body Connection

For years I thought my physical pain and my mental health were two separate problems. I had depression that wouldn't respond fully to medication. Anxiety that would spike randomly. A sense of doom that felt disproportionate to whatever was happening around me. My therapist was great. My antidepressant helped. But something was still off, like I was fighting a war on two fronts and winning on neither.

It wasn't until I understood the mechanics of my endometriosis that I realized these weren't entirely separate problems. They were connected through biological pathways. My brain wasn't the problem. It was responding to years of chronic pain and inflammation.

How Common Are Depression and Anxiety in Endometriosis?

A large retrospective cohort study of over 72,000 women with endometriosis found significantly elevated rates of depression (HR 1.48), anxiety (HR 1.38), and self-directed violence (HR 2.03) compared to matched controls. A Swedish sibling study confirmed the association isn't entirely explained by shared family factors.

The association between endometriosis and mental health conditions is well-documented. A large retrospective cohort study of over 72,000 women with endometriosis found significantly elevated rates compared to matched controls: the adjusted hazard ratio was 1.48 for depression, 1.38 for anxiety, and 2.03 for self-directed violence.

A nationwide Swedish cohort study found that women with endometriosis had increased risk of depressive disorders (HR 1.56), anxiety and stress-related disorders, and other psychiatric conditions — even when compared to their own sisters without endometriosis, suggesting the association isn't entirely explained by shared family factors.

A meta-analysis of 24 studies (nearly 100,000 women) confirmed higher levels of depression among women with endometriosis compared to controls. Importantly, the association was strongest when comparing endometriosis patients to healthy controls, and pain appeared to be a key mediating factor — women with endometriosis and pelvic pain had significantly higher depression levels than those without pain.

This isn't just about being "depressed about having endometriosis." There appear to be biological mechanisms connecting the two conditions.

How Does Inflammation Affect the Brain?

Peripheral cytokines from endometrial lesions can cross the blood-brain barrier, signal through the vagus nerve, and activate brain immune cells called microglia — altering neurotransmitter systems including serotonin, dopamine, and glutamate. Neuroinflammation affects up to 27% of patients with major depressive disorder and is associated with treatment-resistant trajectories.

One of the most important mechanisms connecting endometriosis to mental health involves inflammation. Endometrial lesions produce inflammatory cytokines, including IL-1β, IL-6, and TNF-α. These are chemical messengers that signal danger.

Research shows that peripheral cytokines can affect the brain through several pathways: they can cross the blood-brain barrier, signal through the vagus nerve, and activate immune cells in the brain called microglia. Once inflammation reaches the central nervous system, it can alter neurotransmitter systems including serotonin, dopamine, and glutamate.

This isn't unique to endometriosis. The Lancet's review on depression notes that peripheral cytokines can act directly on neurons and supporting cells after traversing the blood-brain barrier. This helps explain why individuals with autoimmune diseases and chronic inflammatory conditions are more likely to have depression.

Neuroinflammation affects up to 27% of patients with major depressive disorder and is associated with a more severe, chronic, and treatment-resistant trajectory. Higher plasma levels of inflammatory cytokines — most consistently IL-1β, IL-6, and TNF-α — are correlated with greater depressive symptomatology.

What Is the Kynurenine Pathway?

When inflammatory cytokines are elevated, they activate an enzyme that diverts tryptophan — the amino acid precursor to serotonin — away from serotonin production and toward neurotoxic compounds like quinolinic acid. This mechanism is well-established in inflammation-related depression, though its specific role in endometriosis hasn't been extensively studied.

One specific mechanism linking inflammation to depression involves the kynurenine pathway. When inflammatory cytokines are elevated, they activate an enzyme called indoleamine-2,3-dioxygenase (IDO), which diverts tryptophan — the amino acid precursor to serotonin — down an alternative metabolic pathway.

Instead of being converted to serotonin, tryptophan gets converted to kynurenine and its downstream metabolites, including quinolinic acid. Quinolinic acid is neurotoxic and can contribute to excitotoxicity and neuroinflammation.

A systematic review found that interferon-alpha treatment (which activates the immune system) was associated with decreased tryptophan, increased kynurenine, and increased depression scores. This suggests that immune activation can directly affect mood through this pathway.

I want to be clear about what we know: while the kynurenine pathway is well-established in inflammation-related depression generally, the specific role of this pathway in endometriosis-related depression hasn't been extensively studied. The mechanism is plausible but not proven specifically for endometriosis.

What About Estrogen and Mood?

Estrogen fluctuations — rather than simply high or low levels — may be most relevant to mood. A meta-analysis found that exogenous estrogen improved depressive mood in women, with the effect associated with age rather than dose. The primary driver of kynurenine pathway activation is inflammatory cytokines, not estrogen itself.

Research shows that estrogen fluctuations — rather than simply high or low levels — may be most relevant to mood. A meta-analysis of randomized controlled trials found that exogenous estrogen improved depressive mood in women, particularly during perimenopause. The effect was associated with age rather than dose, suggesting that a stable level of estrogen is more beneficial than a high serum level.

Estrogen does modulate neurotransmitter systems, stress axis activation, neuroplasticity, and immune function. A JAMA Psychiatry study found that women with a history of perimenopausal depression were more likely to develop depressive symptoms when estradiol was withdrawn, suggesting some women are more sensitive to estrogen changes than others.

However, the claim that endometriosis-related "estrogen dominance" directly shunts tryptophan away from serotonin production is an oversimplification. While estrogen can influence the kynurenine pathway, the primary driver of kynurenine pathway activation is inflammatory cytokines, not estrogen itself.

Does Pain Itself Cause Depression?

The meta-analysis on endometriosis and depression found that the association is largely determined by chronic pain. Chronic pain and depression share overlapping neural circuits and neurotransmitter systems, and chronic pain causes measurable changes in brain structure and function. Effective pain management is an important component of addressing mental health.

The meta-analysis found that the association between endometriosis and depressive symptoms is largely determined by chronic pain. Women with endometriosis and pelvic pain had significantly higher depression levels than those without pain.

Chronic pain and depression share overlapping neural circuits and neurotransmitter systems. Living with persistent pain is psychologically exhausting. It disrupts sleep, limits activities, strains relationships, and creates uncertainty about the future.

This doesn't mean the depression is "just psychological" — chronic pain causes measurable changes in brain structure and function. But it does mean that effective pain management is an important component of addressing mental health in endometriosis.

What About Medical Trauma?

Many people with endometriosis spent years being dismissed by providers, with average diagnostic delays of 5–12 years. Repeated invalidation from authority figures can affect nervous system regulation, creating hypervigilance and healthcare-specific anxiety that compounds the biological mechanisms already at play.

There's also a psychological and social dimension that compounds this. Many people with endometriosis spent years — sometimes decades — being dismissed. Your pain was "not that bad." Your symptoms were "in your head." You were told to "just have a baby" or "exercise more."

Research confirms this experience. The average diagnostic delay is 5–12 years, and most women see multiple clinicians before receiving a diagnosis. Studies have documented that dismissal and disbelief by medical professionals is a common experience.

Repeated invalidation from authority figures can affect how your nervous system responds. You may become hypervigilant about symptoms. You may develop anxiety about healthcare itself. This psychological burden adds to the biological mechanisms already at play.

Does Treating Endometriosis Improve Mental Health?

A systematic review found that medical and surgical interventions significantly improved quality of life. One study of women with stage 4 endometriosis found significant decreases in depression and increases in sleep quality after surgery. However, postoperative hormonal therapy alone did not significantly reduce psychiatric disorder risk, suggesting a multimodal approach is needed.

The evidence suggests yes. A systematic review found that medical and surgical interventions significantly decreased experienced burdens and improved quality of life in women with endometriosis. Studies specifically examining depression and anxiety have found improvements after surgery.

One study of women with stage 4 endometriosis found a significant decrease in depression complaints and a significant increase in sleep quality after surgery. A meta-analysis found significant improvement in emotional well-being after surgery for all types of endometriosis.

However, a recent study found that postoperative hormonal therapy did not significantly reduce the risk of psychiatric disorders compared to surgery alone. This suggests that while treating the disease helps, the relationship between endometriosis and mental health is complex and may require attention to both physical and psychological factors.

Cognitive behavioral therapy (CBT) has also been shown to help. One study found that CBT combined with usual care significantly reduced anxiety in women after endometriosis surgery compared to usual care alone.

What Can You Actually Do?

Address both sides simultaneously: continue therapy and medication while treating the endometriosis itself. A 2024 review emphasized that a holistic approach combining prompt diagnosis, targeted medical interventions, and psychological support produces the best outcomes.

You're not the problem. Your brain is responding to chronic pain, inflammation, and often years of medical dismissal. That's not weakness.

Address both sides. Continue with therapy and medication if they're helping — that's not wasted effort. But also treat the endometriosis itself, through whatever combination of approaches makes sense for you. Mental health and physical health are connected.

Be patient with the timeline. If inflammation has been affecting your brain for years, improvement may be gradual rather than dramatic. That's still progress.

A 2024 review in Fertility and Sterility emphasized that healthcare providers who treat women with endometriosis should be aware of these associations, recommending "a holistic approach by gynecologists as well as mental health professionals" that emphasizes prompt diagnosis, targeted medical interventions, and psychological support.

You're not losing your mind. Your mind is responding to your body's crisis. Once we address that crisis — through treating the disease, managing pain, and supporting your mental health — things can get better.